NEWS
EXACT Therapeutics Receives Investment from GE HealthCare to Advance Therapeutic Ultrasound in Pancreatic Cancer
AmCham News tags
- Accounting / Financial
- AmCham Norway
- Company Profiles
- Education / Research
- Entertainment
- Food & Beverage
- Government
- Healthcare
- Hotel/ Restaurants/ Conferences
- Insurance
- International Leadership Interview Series
- Membership Guide
- Publications
- Rising Leaders
- Technology
- Trade
- Travel
Business News tags
- Accounting / Financial
- Airline / Travel
- Automobile / Transport
- Chemicals / Metals
- Communications/PR/Media
- Culture / Lifestyle
- Defense / Security
- Education / Research
- Energy
- Entertainment & Lifestyle
- Financial / Investment
- Food & Beverage
- Government
- Health
- Human Resources
- Insurance
- IP & Innovation
- Legal
- Management Consulting
- Manufacturing
- Pharmaceutical
- Politics
- Property / Real Estate
- Seafood
- Shipping & Offshore
- Statistics
- Tax
- Technology
- Trade
< Back to all news
EXACT Therapeutics Receives Investment from GE HealthCare to Advance Therapeutic Ultrasound in Pancreatic Cancer
Business
Date posted: 03.12.2024
Category: Business News
EXACT Therapeutics (Euronext Growth: EXTX) today announced a strategic collaboration with GE HealthCare focused on advancing ultrasound mediated therapeutic enhancement with Acoustic Cluster Therapy (ACT®) within the field of abdominal cancer. As part of the agreement, GE HealthCare will participate as a cornerstone investor, committing 7 MUSD to EXACT Therapeutics’ (EXACT-Tx) planned private placement.
Read full article HERE.
Source: EXACT Therapeutics